---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-059147"
form_type: "8-K"
ticker: "RZLT"
cik: "0001509261"
company_name: "Rezolute, Inc."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T04:01:34.951857+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Rezolute Q3 FY2023 net loss $15.7M; cash $129.2M; Phase 3 for RZ358 on track for Q3 2023

## Summary
- Net loss of $15.7M for Q3 FY2023, compared to $11.2M in same period last year.
- Cash and equivalents $33.7M plus marketable debt securities $95.5M as of March 31, 2023.
- R&D expenses rose to $14.2M from $8.7M, driven by clinical trial and manufacturing costs.
- Company expects to commence Phase 3 study for RZ358 in Q3 calendar 2023; Phase 2 for RZ402 enrolling.
- G&A expenses increased to $2.9M from $2.1M due to higher personnel and stock-based compensation.

## SEC filing metadata
- accession: 0001104659-23-059147
- form_type: 8-K
- ticker: RZLT
- cik: 0001509261
- company_name: Rezolute, Inc.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509261/000110465923059147/0001104659-23-059147-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509261/000110465923059147/tm2315328d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-059147
- JSON: https://secwatch.observer/filing/0001104659-23-059147.json
- Plain text: https://secwatch.observer/filing/0001104659-23-059147.txt

## Key facts
- Earnings Releases
  Rezolute, Inc. reported third quarter of fiscal 2023 ended March 31, 2023 results: net income $15.7 million.
  - Period: third quarter of fiscal 2023 ended March 31, 2023
  - Net income: $15.7 million
  - Result: reported results
  source text: Net loss was $15.7 million for the third quarter of fiscal 2023, compared to $11.2 million for the same period in fiscal 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1509261/000110465923059147/0001104659-23-059147-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.